PCV10 decreases rate of pneumonia among vaccine-eligible children and older, unvaccinated children.
Elevated cardiac troponin T is also strongly prognostic of cardiac mortality observed in association with community-acquired pneumonia.
Factors that contribute to antibiotic choice for CAP include patient age, previous antibiotic receipt, and private insurance.
Researchers observed a 95.3% reduction of Streptococcus pneumoniae bacteremia after implementation of routine immunization with the pneumococcal conjugate vaccine.
Point of care lung ultrasound is an accurate tool for the diagnosis of pneumonia, according to researchers.
Results showed no link between inhaled corticosteroids and risk of pharyngitis, otitis media, or sinusitis.
Findings from a US claims-based retrospective study call for more effective antimicrobial treatments for patients with community-acquired pneumonia.
The ACIP has released the 2017 recommended immunization schedule for adults.
The schedule includes new or revised recommendations for several vaccines for children and adolescents.
Higher-potency statins increased hospitalization for community-acquired pneumonia compared with lower-potency statins.
Endobronchial suture should be considered in patients with recurrent pneumonia that is unresponsive to medical therapy.
Polyvalent pneumococcal vaccines offered protection against community-acquired pneumonia in COPD patients.
The PPSV23 vaccine may not prevent pneumonia in patients with rheumatoid arthritis.
Children with complicated pneumonia should preferentially receive oral antibiotics at discharge when effective oral options are available
Patients with a blood eosinophil count below 2% had a poor response to treatment with inhaled corticosteroids.
It is well-accepted that healthcare practitioners have a duty to their patients, but do patients have a duty as well?
General practices that prescribe fewer antibiotics may encounter slightly higher incidences of pneumonia and peritonsillar abscess.
Patients with mild-to-moderate airflow limitations should be screened for COPD exacerbations.
Patients with COP generally have positive outcomes following a definitive diagnosis and the initiation of appropriate treatment.
The influenza vaccine may be able to prevent approximately 57% of hospitalizations due to influenza pneumonia.
Adults hospitalized with pneumonia benefit from the addition of corticosteroids to antibiotic treatment.
Of the 49,653 patients included in the cohort, 562 were hospitalized for community-acquired pneumonia during follow-up.
Nearly three-quarters of the children studied had viral infections -- either alone or in combination with a bacterial infection.
Patients with severe, community-acquired pneumonia and high inflammatory response benefit from corticosteroids.
Patients in Tennessee aged less than two years experienced about 1,300 fewer pneumonia hospitalizations annually in 2011 and 2012.
Perceived swallowing difficulties and overnight denture-wearing were independently associated with an approximately 2.3-fold higher risk of pneumonia.
More than 50% of children aged less than five years died of complications resulting from infectious diseases.
Although azithromycin is usually first-line treatment, recent evidence has linked the drug with an increased risk of cardiovascular events.
Risk of death at 90 days up for pneumonia patients without preexisting diabetes who present with hyperglycemia.
Thirteen-valent pneumococcal conjugate vaccine might prevent more adult pneumonia than the 23-valent pneumococcal polysaccharide vaccine, at a better price.